HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 79 filers reported holding HARVARD BIOSCIENCE INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,814 | -16.2% | 17,166 | +7.1% | 0.00% | – |
| Q2 2023 | $88,032 | -37.1% | 16,035 | -28.8% | 0.00% | – |
| Q1 2022 | $140,000 | +23.9% | 22,536 | +40.9% | 0.00% | – |
| Q4 2021 | $113,000 | -3.4% | 15,999 | -4.2% | 0.00% | – |
| Q3 2021 | $117,000 | -15.8% | 16,697 | 0.0% | 0.00% | – |
| Q2 2021 | $139,000 | +36.3% | 16,697 | -10.9% | 0.00% | – |
| Q1 2021 | $102,000 | +27.5% | 18,748 | 0.0% | 0.00% | – |
| Q4 2020 | $80,000 | +158.1% | 18,748 | +79.4% | 0.00% | – |
| Q3 2020 | $31,000 | -52.3% | 10,449 | -30.3% | 0.00% | – |
| Q1 2019 | $65,000 | +35.4% | 14,990 | 0.0% | 0.00% | – |
| Q4 2018 | $48,000 | -39.2% | 14,990 | 0.0% | 0.00% | – |
| Q3 2018 | $79,000 | -1.2% | 14,990 | 0.0% | 0.00% | – |
| Q2 2018 | $80,000 | – | 14,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
| 272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
| Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
| Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
| BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
| Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
| Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
| Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
| HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |